I had an appointment with the NP at my oncologist's office a couple weeks ago. We discussed the fact that my PSA has been creeping upwards this year and I wondered whether it's just the inevitable failure of Nubeqa, or if my switch from Lupron to Orgovyx last November might be a factor. I started Nubeqa in Feb 2020 and aside from the side effects, I have been pretty happy with how well it has worked. After starting it my PSA dropped to 0.04 at one point and yes it crawled up, but this year the momentum has increased. My PSA test last month was 0.58, in May it was 0.45, in Feb it was 0.29, and the one prior to that, the day before I started Orgovyx, it was 0.28. I know we need to watch the acceleration rate, not just the numbers, but does the hivemind here think it's time to jump to Pluvicto when I'm at 0.58?
I've never had huge numbers. My PSA at diagnosis in 2010 was 4.7 and the highest it has ever reached, in 2018 right before I started docetaxel, it was about 16.7.
As for the Orgovyx, I was the first patient my oncologist has ever prescribed that medication and according the the NP, I'm still the only one in his practice. It was done at my request at the time. Lately though, I've already been thinking perhaps I should switch back. I don't mind taking the pills, but the injections every six months aren't such a hassle either. One thing I wanted to get away from with Orgovyx is the hormone swings at the start and finish of each cycle with the injections, but I've seen enough even with Orgovyx, mainly emotional swings, that I think that factor is pretty much a wash. I'm also nervous about the number of drug interactions with Orgovyx. The oncologist wants me to switch back to Lupron and I'm OK with that.